Recombinant human interleukin 10 for induction of remission in Crohn's disease

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Buruiana, F ^b   Alonso Coello, Pablo ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 10;

CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROHN DISEASE; DATA EXTRACTION; DRUG EFFICACY; DRUG TOLERABILITY; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTERVENTION STUDY; MEDICAL INFORMATION; MEDICAL RESEARCH; RANDOMIZED CONTROLLED TRIAL; REMISSION; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 44949162009     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005109.pub2     Document Type: Review

References (7)

1. Alderson 2004 Alderson P, Green S, Higgins JPT, editors. Assessment of study quality. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]; Section 6. The Cochrane Library 2004, Issue 1.
2. Chalmers 1983 Chalmers TC, Celano P, Sacks HS, Smith H. Bias in treatment assignment in controlled clinical trials. N Engl J Med 1983;309(22): 1358-61. [MEDLINE: 6633598].
3. Fedorak 2000 Fedorak RN, Gangl A, Elson CO, Rutgeerts P, Schreiber S, Wild G, et al.Recombinant human interleukin 10 in the treatment of patients with mild to moderately severe active Crohn's disease. Gastroenterology 2000;119(6):1473-82. [MEDLINE: 11113068].
4. Jadad 1996 Jadad AR, Moore A, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996;17(1):1- 12. [MEDLINE: 8721797].
5. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported inmeta-analyses?. Lancet 1998;352(9128):609-13. [MEDLINE: 9746022].
6. Schultz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12. [MEDLINE: 7823387].
7. van Deventer 1997 van Deventer SJ, Elson CO, Fedorak RN. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Gastroenterology 1997;113(2):383-9. [MEDLINE: 9247454].